Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | AKT1 | P31749 | 2/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | CDC25A | P30304 | 1/20 | 0.57 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | PTAFR | P25105 | 1/20 | 0.47 |
| ▸ | HTR1D | P28221 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.43 |
| ▸ | PRKCG | P05129 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2120096 | 0.99 | LMNA (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL223046 | 0.99 | LMNA (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL2118062 | 0.99 | LMNA (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1260875 | 0.99 | LMNA (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL2117527 | 0.99 | LMNA (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL2122717 | 0.99 | LMNA (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| Phosphoric Acid SCHEMBL2035967 | 0.97 | LMNA (0.55) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1261204 | 0.97 | LMNA (0.54) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1260055 | 0.94 | AKT1 (0.50) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1261300 | 0.94 | AKT1 (0.50) | LMNAAKT1ESR1ADORA3CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4121802-B1 | HIGH REFRACTIVE INDEX SILOXANE INSERT MATERIALS FOR EMBEDDED CONTACT LENSES | ALCON INC (CH) | 2024-07-17 | — | — | EP | claimed |
| EP-4076916-B1 | WETTABLE SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-06-12 | — | — | EP | claimed |
| EP-4369081-A2 | METHOD FOR PRODUCING AN OPHTHALMIC PRODUCT | Alcon Inc. (CH) | 2024-05-15 | — | — | EP | claimed |
| EP-4121801-B1 | INSERT MATERIALS WITH HIGH OXYGEN PERMEABILITY AND HIGH REFRACTIVE INDEX | ALCON INC (CH) | 2024-04-17 | — | — | EP | claimed |
| US-11931454-B2 | Wet-packed soft hydrogel ocular inserts | ALCON INC. (CH) | 2024-03-19 | — | — | US | claimed |
| EP-4146461-B1 | METHOD FOR PRODUCING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-03-13 | — | — | EP | claimed |
| EP-4118134-B1 | PHOTOCHROMIC POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS | ALCON INC (CH) | 2024-02-28 | — | — | EP | claimed |
| US-11867874-B2 | Insert materials with high oxygen permeability and high refractive index | ALCON INC. (CH) | 2024-01-09 | — | — | US | claimed |
| WO-2023228055-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-30 | — | — | WO | claimed |
| US-20230374306-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-23 | — | — | US | claimed |
| US-20130306550-A1 | REVERSE OSMOSIS MEMBRANE HAVING GOOD ANTIFOULING PROPERTIES AND METHOD OF MANUFACTURING THE SAME | LG CHEM, LTD. (KR) | 2013-11-21 | — | — | US | claimed |
| EP-2662070-A2 | CROSS-LINKED COPOLYMER CONTAINING PHOSPHORYLCHOLINE MONOMER AND COSMETIC COMPOSITION CONTAINING SAME | KCI Limited. (KR) | 2013-11-13 | — | — | EP | claimed |
| US-20130295038-A1 | Cross-Linked Copolymer Containing Phosphorylcholine Monomer and Cosmetic Composition Containing Same | KCI LIMITED (KR) | 2013-11-07 | — | — | US | claimed |
| US-8278097-B2 | Method for forming embryoid bodies | NOF CORPORATION (JP) | 2012-10-02 | — | — | US | claimed |
| US-20090246871-A1 | For forming embryoid bodies from embryonic stem (ES) cells easily and efficiently without complicated technique | NOF CORPORATION (JP) | 2009-10-01 | — | — | US | claimed |
| US-20060252148-A1 | For forming embryoid bodies from embryonic stem (ES) cells easily and efficiently without complicated technique | NOF CORPORATION (JP) | 2006-11-09 | — | — | US | claimed |
| WO-2003026489-A2 | BIOPOLYMER AND BIOPOLYMER-CELL COMPOSITIONS FOR NERVE TISSUE REPAIR | UNIVERSITY OF FLORIDA (US) | 2003-04-03 | — | — | WO | claimed |
| EP-0537972-B1 | Treating solution for contact lenses | NOF CORP (JP) | 1996-07-10 | — | — | EP | claimed |
| US-5461433-A | Cleaning contact lens by immersing in solution containing copolymer where one of the monomers contains phsophate and tertiary ammonium groups | NOF CORPORATION (JP) | 1995-10-24 | — | — | US | claimed |
| EP-0537972-A1 | Treating solution for contact lenses | NOF CORPORATION (JP) | 1993-04-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130295038-A1 | Cross-Linked Copolymer Containing Phosphorylcholine Monomer and Cosmetic Composition Containing Same | PHOSPHO1, SGMS1, SGMS2 | LMNA 1174/4885AKT1 244/4885ESR1 1448/4885 |
| US-11931454-B2 | Wet-packed soft hydrogel ocular inserts | BRI3BP, BRWD1, HRH2 | LMNA 3870/4885AKT1 3897/4885ESR1 2459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.